AMA Honors Moul For 'US TOO' Support
BETHESDA, Md--Judd W. Moul, MD, director of the Center for Prostate Disease Research (CPDR), established by Congress in 1991, has been awarded the American Medical Association's Young Physicians Section Community Service Award for his role in helping to establish prostate cancer patient support groups within the military health-care system.
BETHESDA, Md--Judd W. Moul, MD, director of the Center for ProstateDisease Research (CPDR), established by Congress in 1991, hasbeen awarded the American Medical Association's Young PhysiciansSection Community Service Award for his role in helping to establishprostate cancer patient support groups within the military health-caresystem.
Dr. Moul, an Army physician and urologist, was instrumental inestablishing a charter chapter of US TOO, the prostate cancersupport group, at Walter Reed Army Medical Center in Washington,DC, in 1991. Since then, the chapter has become the largest prostatecancer support group in the United States. Dr. Moul is also anadvisor to the US TOO International, Inc. organization.
Prolaris in Practice: Guiding ADT Benefits, Clinical Application, and Expert Insights From ACRO 2025
April 15th 2025Steven E. Finkelstein, MD, DABR, FACRO discuses how Prolaris distinguishes itself from other genomic biomarker platforms by providing uniquely actionable clinical information that quantifies the absolute benefit of androgen deprivation therapy when added to radiation therapy, offering clinicians a more precise tool for personalizing prostate cancer treatment strategies.
CCR Scores and Beyond: Precision Strategies for Treatment Intensification in Prostate Cancer
April 15th 2025Alvaro Martinez, MD discusses how emerging genomic risk stratification tools such as the clinical cell-cycle risk (CCR) score are transforming personalized prostate cancer treatment by enabling more nuanced assessments of metastasis risk and treatment intensification strategies beyond traditional NCCN risk groupings.
